PDSB
PDS Biotechnology Corp
1.20$
+60.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +103.6% | +602.7% | +70.1% | +88.5% | +82.7% | -62.2% | +42.4% | -84.1% | -65.7% | -98.4% | +20,084.9% | +21.6% | +3.4% | |
| – | – | +398.5% | +123.3% | +83.0% | +20.6% | +19.0% | -58.3% | -85.8% | +808.8% | +26.4% | +46.5% | -10.1% | -40.0% | |
| – | – | – | – | – | -30.6% | +196.0% | -724.0% | – | +609.9% | +19.4% | – | – | – | |
| – | -208.6% | – | -26.0% | -37.7% | +292.9% | -211.5% | – | – | -92.9% | +5,802.3% | -104.5% | – | – | |
| – | +22,322.3% | +546.0% | +47.5% | -47.4% | -72.5% | -100.0% | -66.7% | +400.0% | -20.0% | +0.0% | +0.0% | +724,900.0% | -100.0% | |
| – | +22,285.6% | +546.0% | +47.5% | -47.4% | -72.5% | – | +0.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -99.8% | +5,473.5% | -95.9% | +4.0% | +3,876.9% | – | – | – | – | – | |
| – | – | – | – | – | -98.8% | -193.0% | – | +0.0% | +0.0% | -1.8% | -100.2% | +5,263.9% | +137.8% | |
| – | +570.0% | +3.6% | +747.1% | -93.5% | +148.3% | -189.9% | – | +3,876.9% | +63.9% | -29.9% | -52.2% | +23.3% | -36.7% | |
| – | – | -23.9% | +1,883.6% | -120.4% | – | – | – | +38.3% | +118.3% | -76.4% | -301.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.